Please login to the form below

compulsory licensing

This page shows the latest compulsory licensing news and features for those working in and with pharma, biotech and healthcare.

Labour Party takes aim at pharma, calls attention to Orkambi row

Proposal to introduce compulsory licensing faces industry criticism. Labour Party leader Jeremy Corbyn has announced plans to “take on pharmaceutical companies” in his speech at the Labour Party Conference in Brighton. . ... Industry response. The

Latest news

Who's calling the shots in European healthcare?

In April, the EMA published a paper about added therapeutic benefits and drug licensing.it is now engaging with affordability arguments, so it can’t bury its head in the sand ... In 2019, we’ve seen government ministers in the House of Commons
Orkambi row: government now considering Crown Use licensing

These would include a compulsory licensing approach called Crown Use licensing or large scale clinical trials sponsored by the government. ... Despite momentum growing behind the call for compulsory licensing, campaigners know that the process would
Buyers’ Club wants government support on Orkambi imports

compulsory licensing) crown use licence, launch a large scale clinical trial and provide direct support for individuals using the buyers’ club.
Orkambi buyers’ club set up to gain access to cheaper versions

The group wants the government to use its compulsory licensing laws, called Crown Use licence to bypass Vertex’s UK patents and procure these cheaper copies for use on the NHS.
How to fix a problem like Orkambi? Solutions suggested ahead of showdown

This has led to the creation of Just Treatment, a new patient action group which is advocating the compulsory licensing of Vertex to break the deadlock, so-called Crown use licensing.

More from news
Approximately 1 fully matching, plus 21 partially matching documents found.

Latest Intelligence

The Cystic Fibrosis Buyers’ Club

Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence.
The Orkambi row explained

It has called for a Crown Use compulsory licensing of Orkambi, but this always looked like an outside bet. ... It urges the government to use Crown use compulsory licensing to gain access to cheaper versions of Orkambi.
#OrkambiNow?

UK government to issue a compulsory licensing of Orkambi. ... For example in Germany, from the time of European licensing, adults and children of 12 and over were able to access Orkambi if they had the right mutations.”.
Stress testing for the perfect compliance storm

Some markets have introduced charges for access to state healthcare premises or compulsory licensing, and some HCOs are now seeking direct support either as financial donations or as medical education, patient
Intellectual property threats in the BRIC markets

However, China also passed the “Measures for the Compulsory Licensing of Patent Implementation” law in May 2012. ... There are two ways of interpreting recent trends in compulsory licensing and IP loss.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Account Management: Competitive Salary Offered

Principal Medical Writer: Varies on experience

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Senior Content Editor - Biotechnology: Salary TBC

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

PMHub

Add my company

integrated medhealth communication

imc provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including...

Latest intelligence

WHITE PAPER: Why do men die younger?: It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials: Here are some useful tips to help get your hands on authentically diverse stock photos....
Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...